Research

The NSW Government is committed to making NSW a preferred destination for research that improves the evidence base for cannabis products to relieve sickness and suffering.

NSW has a supportive environment for research into medicinal cannabis. There are currently a number of universities and research centres conducting research into medicinal cannabis across NSW.

This includes initiatives such as the Lambert Initiative, which received a major philanthropic donation from Barry and Joy Lambert for $33.7 million. The Lambert Initiative will explore the potential of cannabis-derived compounds in treating a range of debilitating diseases. This will involve medicinal chemistry, cellular and preclinical research, early human testing and clinical trials in patients, with the overall aim to optimise and introduce safe and effective cannabinoid therapeutics into mainstream medicine nationally and internationally.

For information about regulation of research activities, contact the Pharmaceutical Services Unit, within the NSW Ministry of Health. It is responsible for the administration of the Poisons and Therapeutic Goods Act 1966 (NSW) and the Poisons and Therapeutic Goods Regulation 2008 (NSW), and the development of policies and guidelines to complement the legislation. The Pharmaceutical Services Unit can be contacted at: pharmserv@doh.health.nsw.gov.au or (02) 9391 9944.